In preclinical models of myocardial infarction, quercitrin administration improved cardiac remodeling by promoting M2-like macrophage polarization, characterized by upregulation of Arg1, Ym1, and Mrc1, and by enhancing mitochondrial oxidative metabolism and reducing intracellular ROS levels (69). This evidence concerns the gene ARG1 and myocardial infarction.